Patent ID: 8034369

Claim:
A controlled release bioactive agent delivery device for treatment of an eye, the device comprising: a) a body member having a direction of extension, a longitudinal axis along the direction of extension, and a proximal end and a distal end, wherein at least a portion of the body member deviates from the direction of extension; and b) a polymeric coated composition in contact with a surface of the body member to provide a coated surface, the polymeric coated composition comprising a first polymer, a second polymer, and a bioactive agent, wherein the first polymer and the second polymer are hydrophobic, and wherein the first polymer comprises polyalkyl(meth)acrylate, aromatic poly(meth)acrylate, or a combination thereof, and wherein the second polymer comprises polyethylene-co-vinyl acetate), wherein the body member has a length such that, upon placement of the device at an implantation site within a posterior segment of an eye, the device does not enter a central visual field of the eye, and wherein the bioactive agent is present in an amount in the range of 1 μg to 10 mg of bioactive agent per cm 2 of the coated surface of the device.